STEM-Talk

Dawn Kernagis and Ken Ford

Dive into the fascinating world of science and technology with "STEM-Talk," hosted by Dawn Kernagis and Ken Ford. This podcast offers listeners an unparalleled opportunity to explore groundbreaking research and insights from the leading minds in science, engineering, and medicine. Each episode delves into conversations with distinguished researchers and innovators, unpacking complex scientific concepts and discussing their real-world applications. Whether you're a science enthusiast or a professional in the field, "STEM-Talk" provides a unique platform to discover the latest advancements and trends shaping our future. The show’s hosts, Dr. Dawn Kernagis, a bioastronautics researcher, and Dr. Ken Ford, an AI and computer science expert, bring their deep knowledge and infectious curiosity to every discussion. Together, they ensure that "STEM-Talk" is not just informative but also engaging, making cutting-edge science accessible to a broader audience. Tune in to "STEM-Talk" to stay connected with the evolving world of STEM and be inspired by the stories of innovation and discovery that are driving progress in every corner of the globe.

Episodes

  • Episode 169: Dave Feldman talks about cholesterol and the ketogenic diet

    In episode 169 of STEM Talk, hosts Dawn Kernagis and Ken Ford interview Dave Feldman, an engineer turned self-experimenter who delves deep into the effects of a ketogenic diet on cholesterol levels. Feldman, founder of the Citizen Science Foundation, shares insights from his journey exploring the relationship between diet, cholesterol, and overall health. He discusses his initial alarming increase in cholesterol after starting a ketogenic diet and his subsequent research into lipidology, leading to the development of the "Lipid Energy Model." This model suggests a complex interaction between dietary fat intake, cholesterol levels, and metabolic health. The episode is a blend of personal anecdotes, scientific discussion, and practical advice for those interested in the metabolic impacts of dietary choices.

  • Episode 168: Alessio Fasano discusses celiac disease and gluten-related disorders

    In this enlightening discussion, Dr. Alessio Fasano, accompanied by hosts Dawn Kernagis and Ken Ford, explores the complex world of celiac disease, gluten sensitivity, and the gut microbiome. Fasano, renowned for his groundbreaking work, shares insights from his research at the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital. Topics include the genetic predispositions of celiac disease, the impact of intestinal permeability on autoimmune diseases, and the promising avenues for new treatments beyond the gluten-free diet. The episode also highlights Fasano’s recent studies, books, and an international consortium project aimed at understanding celiac disease from infancy.

  • Episode 167: Nicholas Norwitz discusses a ketogenic diet as metabolic medicine

    Dr. Nicholas Norwitz, a Harvard medical student, discusses his personal and professional journey with a ketogenic diet as a form of metabolic medicine. After facing serious health challenges, including osteoporosis and inflammatory bowel disease (IBD), Norwitz adopted a ketogenic diet, which dramatically improved his conditions. He shares his insights on the biological mechanisms behind the diet's effectiveness, particularly its impact on lipid profiles and metabolic health. The episode delves into the complexities of diet and cholesterol, discussing a controversial experiment where Norwitz compared the effects of Oreo cookies and statins on his LDL cholesterol levels, highlighting the nuanced interplay between diet, metabolic health, and traditional medical treatments.

  • Episode 166: Vyvyane Loh and Ken Ford discuss atherosclerotic heart disease

    In this insightful episode, Dr. Jonathan Edwards, an anesthesiologist and medical practitioner, shares his extensive experience using ketamine in clinical settings. He discusses its development, initial medical uses, and significant effectiveness in treating depression and suicidal ideation, highlighting its safety when used under medical supervision despite its potential for abuse. The episode delves into the complexities of ketamine's impact on mental health, addressing both its therapeutic potentials and the risks associated with its misuse. The conversation also touches upon the broader implications of psychedelic therapies in mental health, advocating for combined approaches involving both medication and psychotherapy to ensure effective treatment outcomes.